Oncology
Clinical research in non-small cell lung cancer includes studies in metastatic non-squamous disease and settings involving surgery and adjuvant treatment, with attention to treatment comparability against established PD-1 immunotherapy standards.
- Metastatic non-squamous NSCLC
- Early and locally advanced lung cancer
- Immuno-oncology treatment comparison
The sponsor’s oncology portfolio is centered on therapies used in advanced and earlier-stage lung malignancies.
Retinal diseases
Ophthalmic research focuses on neovascular age-related macular degeneration, macular oedema secondary to retinal vein occlusion, and myopic choroidal neovascularization, reflecting interest in vision-threatening retinal vascular disorders.
- Neovascular AMD
- Retinal vein occlusion-related macular oedema
- Myopic CNV
These studies align with treatment areas where intravitreal biologics are used to manage retinal fluid and abnormal vessel growth.
Biologic comparability
The sponsor’s trials include head-to-head evaluation of biosimilar candidates against reference biologics, with emphasis on efficacy, safety, and tolerability in both oncology and ophthalmology.
- Biosimilar development
- Reference biologic comparison
- Clinical equivalence assessment
This area supports the development of alternative biologic therapies across cancer and eye disease indications.
Intravitreal administration
Research activity also includes evaluation of pre-filled syringe use for intravitreal injection in retinal disease, with attention to preparation and administration by healthcare professionals.
- Pre-filled syringe usability
- Intravitreal delivery
- Healthcare professional administration
These studies are relevant to retinal therapies requiring precise ocular delivery.
